1-Hydrazinophthalazine (apresoline) in hypertension (Q73404739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

1-Hydrazinophthalazine (apresoline) in hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

E HARRIS

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R TURNER

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 1954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

6809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

429-433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

The place of the hydrazinophthalazine and thiophanium complications of pregnancy

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

The activities of 1-hydrazinophthalazine (Ba-5968); a hypotensive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Observations on alleged serotonin- (enteramine)-like nature of cerebral pressor substance of Taylor, Page, and Corcoran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Suppression of vasomotor reflexes in man following L-hydrazinophthalozine (C-5968)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Evaluation of renal resistances, with special reference to changes in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Caution with regard to use of hexamethonium and "apresoline"

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Eine neue Gruppe blutdrucksenkender Substanzen von besonderem Wirkungscharakter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

[Inhibition of histaminase by phthalazin derivatives]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

1-Hydrazinophthalazine; apresoline in the treatment of hypertension: a two year study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Effect of hydralazine in hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Effect of hypotension producing drugs on the renal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Treatment of essential and malignant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Renal hyperemia induced in man by a new phthalazine derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

The control of hypertension with 1-hydrazinophthalazine (apresoline)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

The effect of 1-hydrasinophthalasine in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Hypertensive cardiovascular disease; effect of thoracolumbar splanchnicectomy on mortality and survival rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

A hormonal neurogenic vasopressor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2854%2991138-1

7 January 2021

10.1016/S0140-6736(54)91138-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13131873%20AND%20SRC:MED&resulttype=core&format=json